Migraine Clinical Trials in Stamford, Connecticut

5 studies are recruiting for migraine in Stamford, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe of migraine.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Ki Health Partners, LLC, Stamford, Connecticut
    Locations
    72 in total
    Run by
    TriGemX Bio, Inc.

    See if you can join NCT07816367 on ClinicalTrials.gov

  2. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

    Stage
    Phase 3
    Ages
    6 to 17
    Site
    New England Institute for Clinical Research (NEICR) - Stamford, Stamford, Connecticut
    Locations
    64 in total
    Run by
    H. Lundbeck A/S

    See if you can join NCT05164172 on ClinicalTrials.gov

  3. Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

    This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the study. Neither partic…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    New England Institute for Clinical Research, Stamford, Connecticut
    Locations
    20 in total
    Run by
    Aspeya, Inc.

    See if you can join NCT07646613 on ClinicalTrials.gov

  4. Study of EVO756 in Adults With Migraine

    This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    New England Institute for Neurology and Headache, Stamford, Connecticut
    Locations
    35 in total
    Run by
    Evommune, Inc.

    See if you can join NCT07616128 on ClinicalTrials.gov

  5. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

    Stage
    Phase 3
    Ages
    6 to 17
    Site
    New England Institute for Clinical Research /ID# 230635, Stamford, Connecticut
    Locations
    129 in total
    Run by
    AbbVie

    See if you can join NCT05125302 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.